Aerie Pharmaceuticals, Inc. Convertible Debt
Aerie Pharmaceuticals, Inc. had Convertible Debt of $125.00 million as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2016-11-03
- 2016-09-30: Convertible Debt $125.00M.
- 2016-06-30: Convertible Debt $125.00M.
- 2016-03-31: Convertible Debt $125.00M.
- 2015-12-31: Convertible Debt $125.00M.
| Period end | Convertible Debt |
|---|---|
| 2016-09-30 | $125.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $125.00M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $125.00M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $125.00M 10-K · filed 2016-03-02 |
| 2014-12-31 | $125.00M 10-K · filed 2015-02-27 |